Ilico Genetics
Santiago, CL · Founded 2020 · 5 employees on LinkedIn · 2 known investors
Find your way into Ilico Genetics
Each arrow is one introduction. Sign up to fill in the first one.
Ask Mario Mora to introduce you to Fernando Alarcon
You →Mario · together at Entel →Fernando
Ask Jamie Chen to introduce you to Alejandro Corvalán
You →Jamie · together at MD Anderson Cancer Center →Alejandro
Sign up to find every way you can get introduced to Ilico Genetics
- Your email: who you already know at Ilico Genetics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Ilico Genetics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Ilico Genetics develops a blood-based molecular test for the early detection of gastric cancer using methylated DNA markers, designed to identify disease years before traditional methods. The company serves gastroenterologists and patients in the oncology diagnostics space, with a platform technology applicable to precision medicine and disease prevention.
Founders & leadership
Ilico Genetics was founded in 2020 by Alejandro Corvalán.


Investors · 2
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$457.7K disclosed across 1 of 2 rounds · 2023
- Undisclosed amountSAFE roundSep 2023
Life Science Greenhouse Investments
Source ↗
▶$457.7KraisedOct 2023 · 10 investors · BiotechnologyRule 506(b)
- Maria Jose Maturana RojasDirector
- Alejandro Hernan Corvalan RodriguezDirector
- Fernando A Alarcon HardyExecutive Officer, Director
- Amount sold
- $457.7K
- Proceeds to insiders
- $75K
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Ilico Genetics do?
- Ilico Genetics develops a blood-based molecular test for the early detection of gastric cancer using methylated DNA markers, designed to identify disease years before traditional methods. The company serves gastroenterologists and patients in the oncology diagnostics space, with a platform technology applicable to precision medicine and disease prevention.
- Who founded Ilico Genetics?
- Ilico Genetics was founded by Alejandro Corvalán in 2020.
- Who are Ilico Genetics's investors?
- Ilico Genetics's investors include Life Sciences Greenhouse Investments.
- How much funding has Ilico Genetics raised?
- Ilico Genetics has disclosed $457.7K raised across 1 of its 2 known rounds.
- Where is Ilico Genetics headquartered?
- Ilico Genetics is headquartered in Santiago, CL.


